Healthcare Sector Review: 1/10/25
Regime Change: Was it a coincidence that biotechs started to struggle mightily after the first full month in office in February 2021 a huge top for the group? Notice the cratering after the bearish shooting star that month, which started a more than 100-handle descent to the lows made in May 2022. The good sign is that it is holding north of the break ABOVE the bearish head and shoulders formation and we know from FALSE moves come fast ones in the opposite direction. It is still within the bull flag and trading in a taut range between the very round 90-100 numbers. Over the last year on an intramonth basis it traded above par 7 times, but only one month was able to CLOSE above 100, last August. Suffice to say, that is a big line in the sand going forward in 2025, and a break above carries a measured move to 135. The WEEKLY chart is a bit more ominous as it still trades below the nasty bearish engulfing candle the week ending 11/15 which slumped 12% in enormous volume. A bearish death cross is happening, but those occur after most of the technical damage has been done, and the last 3 weeks have defended the important very round 90 number. The daily chart of the XBI below shows CLOSES above 90 are imperative, as just a few below that number have occurred but the worst being 12/19 by 17 cents. Good risk/reward here for the group.